Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.

Kara Z., Akçin R., Demir A. N., Dinç H. Ö., Taşkın H. E., Kocazeybek B. S., ...Daha Fazla

Obesity surgery, cilt.32, sa.9, ss.2987-2993, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 9
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s11695-022-06181-y
  • Dergi Adı: Obesity surgery
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2987-2993
  • Anahtar Kelimeler: Severe obesity, Vaccines, Antibody response, INFLAMMATION, COVID-19
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Aim Obesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim is to investigate the spike-protein receptor-binding domain antibody titers against BNT162b2 mRNA and inactivated SARS-CoV-2 (CoronaVac) vaccines in people with severe obesity. It is anticipated that the results to be obtained may provide invaluable information about future SARS-CoV-2 vaccination strategies in this vulnerable population.